BCIQ Profiles

Company Profile ReportTarget Profile Report

Alizé seeks to build out company with largest European A round this year

French biotech Alizé Pharma 3 is taking a more ambitious approach than its predecessors, and now has a €67 million ($74.5 million) series A round to fund two endocrine programs through Phase II testing and expand into

Read the full 375 word article

How to gain access

Continue reading with a
two-week free trial.